Qiong Shi

This inventor holds 9 USPTO granted patents and 7 published patent applications and 10 EPO patents. Top assignees: Bgi-Shenzhen Co., Limited, Bgi Shenzhen. Active years: 2018-2020.

USPTO Granted Patents = 9 (Patent Applications = 7)

% Patents Active = 100.0

EPO Patents = 10 (Patent Applications = 16)

Average Co-Inventor Count = 7.5

ph-index = 1

Forward Citations = 1(Granted Patents)

Company Filing History:

5 out of 14

Bgi-Shenzhen Co., Limited

Years Active: 2018-2020

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10858407 - Conotoxin polypeptide K-CPTX-BT102, and method for preparation thereof and application thereof (2020-12-08),

2. 10858406 - Conotoxin polypeptide κ-CPTx-bt105, and method for preparation thereof and application thereof (2020-12-08),

3. 10662228 - Conotoxin polypeptide κ-CPTx-bt103, and method for preparation thereof and application thereof (2020-05-26),

4. 10633416 - Conotoxin polypeptide κ-CPTx-bt104, and method for preparation thereof and application thereof (2020-04-28),

5. 10556927 - Conotoxin peptide κ-CPTx-btl03, preparation method therefor, and uses thereof (2020-02-11),

6. 10501498 - Conotoxin peptide κ-CPTx-BTL01, preparation method therefor, and uses thereof (2019-12-10),

7. 10246490 - Conotoxin peptide κ-CPTX-BTL02, preparation method therefor, and uses thereof (2019-04-02),

8. 10179802 - Conotoxin peptide κ-CPTX-BTL04, preparation method therefor, and uses thereof (2019-01-15),

9. 10087216 - Conotoxin polypeptide κ-CPTx-bt101, and method for preparation thereof and application thereof (2018-10-02),

Title: Innovations of Qiong Shi in Conotoxin Polypeptides

Introduction

Qiong Shi is a notable inventor based in Guangdong, China. He has made significant contributions to the field of biochemistry, particularly in the development of conotoxin polypeptides. With a total of 9 patents to his name, his work has implications for various applications in medicine and biotechnology.

Latest Patents

Among his latest patents are two conotoxin polypeptides. The first is the conotoxin polypeptide K-CPTx-bt105, which consists of 16 amino acids and has a molecular weight of 1626.62 daltons. Its full sequence is GICCVDDTCTTHSGCL (SEQ. ID NO. 1). The second patent is for the conotoxin polypeptide K-CPTX-BT102, which consists of 15 amino acids and has a molecular weight of 1660.61 daltons, with the full sequence RCRCEQTCGTCVPCC (SEQ. ID NO. 1). Both patents include methods for preparation and applications of these polypeptides.

Career Highlights

Qiong Shi has worked with BGI Shenzhen Co., Limited, a prominent company in the field of genomics and biotechnology. His work there has allowed him to explore innovative solutions and contribute to advancements in scientific research.

Collaborations

Some of his notable coworkers include Jie Liu and Zhilong Lin, who have collaborated with him on various projects. Their teamwork has fostered an environment of innovation and creativity in their research endeavors.

Conclusion

Qiong Shi's contributions to the field of conotoxin polypeptides highlight his innovative spirit and dedication to scientific advancement. His patents and collaborations reflect a commitment to improving biotechnological applications.